Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	49	non-cytoplasmic
50	72	transmembrane
73	80	cytoplasmic
81	100	transmembrane
101	105	non-cytoplasmic
106	128	transmembrane
129	140	cytoplasmic
141	164	transmembrane
165	169	non-cytoplasmic
170	189	transmembrane
190	232	cytoplasmic
233	258	transmembrane
259	269	non-cytoplasmic
270	290	transmembrane
291	299	cytoplasmic
300	319	transmembrane
320	324	non-cytoplasmic
325	349	transmembrane
350	359	cytoplasmic
360	380	transmembrane
381	391	non-cytoplasmic
392	411	transmembrane
412	426	cytoplasmic

Input:
>BWI76_RS26955
MNSSTNATKRWWYIMPIVFITYSLAYLDRANFSFASAAGITEDLGITKGISSLLGALFFL
GYFFFQIPGAIYAERRSVRKLIFICLILWGACASLTGMVHNIPALAAIRFILGVVEAAVM
PAMLIYISNWFTKSERSRANTFLILGNPVTVLWMSVVSGYLIQAFGWREMFIIEGVPAVI
WAFCWWVLVKDKPSQVNWLAESEKAALQEQLEREQQGIKPVRNYGEAFRSRNVVLLCMQY
FAWSIGVYGFVLWLPSIIRSGGENMGMVEVGWLSSVPYLAATIAMIVVSWASDKMQNRKL
FVWPLLLIAAFAFIGSWAVGANHFWVSYTLLVIAGAAMYAPYGPFFAIIPEMLPRNVAGG
AMALINSMGALGSFFGSWFVGYLNGTTGSPSASYIFMGVALFVSVWLTLIVKPANNQKLP
LGARHA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server